A new study analyses the influence that certain birth and infancy characteristics have on mammographic density - an important indicator of breast cancer risk. The results reveal that women born to mothers aged over 39 years and women who were taller and thinner than the average girl prior to puberty have a higher breast density. […]
Filed under: Breast Cancer on February 9th, 2012 | No Comments »
A study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, reveals that breast cancer cell proliferation was not lowered with soy isoflavone supplements in a randomized human trial. Isoflavone are components of soy foods believed to have anti-estrogen activity…
More: continued here
Filed under: Breast Cancer on February 9th, 2012 | No Comments »
A study published in Cancer Prevention Research, a journal of the American Association for Cancer Research, reveals that breast cancer cell proliferation was not lowered with soy isoflavone supplements in a randomized human trial. Isoflavone are components of soy foods believed to have anti-estrogen activity…
More: continued here
Filed under: Breast Cancer on February 9th, 2012 | No Comments »
A new study analyses the influence that certain birth and infancy characteristics have on mammographic density - an important indicator of breast cancer risk. The results reveal that women born to mothers aged over 39 years and women who were taller and thinner than the average girl prior to puberty have a higher breast density. […]
Filed under: Breast Cancer on February 9th, 2012 | No Comments »
Another layer in breast cancer genetics has been peeled back. A team of researchers at Jefferson’s Kimmel Cancer Center (KCC) led by Richard G. Pestell, M.D., PhD…
More: continued here
Filed under: Breast Cancer on February 9th, 2012 | No Comments »
The internet is awash with stories of how silver can be used to treat cancer. Now, lab tests have shown that it is as effective as the leading chemotherapy drug - and may have fewer side-effects…
More: continued here
Filed under: Breast Cancer on February 9th, 2012 | No Comments »
Combination drug therapy may be needed to combat non-small cell lung cancer (NSCLC), according to a study by the Translational Genomics Research Institute (TGen) and Van Andel Research Institute (VARI). The study, “STAT3 is Activated by JAK2 Independent of Key Oncogenic Driver Mutation in Non-Small Cell Lung Carcinoma,” was published online by the Public Library […]
Filed under: Breast Cancer on February 5th, 2012 | No Comments »
According to an investigation in the February 1 issue of JAMA, surgery to remove additional tissue (reexcision) is required in almost 1 in 4 women who undergo a partial mastectomy for breast cancer treatment. In addition, there is considerable surgeon and institutional difference in the rate of reexcisions that have nothing to do with patients’ […]
Filed under: Breast Cancer on February 4th, 2012 | No Comments »
Genome Research publishes online and in print a special issue entitled, “Cancer Genomics,” highlighting insights gained form cutting-edge genomic and epigenomic analyses of cancer…
More: continued here
Filed under: Breast Cancer on February 3rd, 2012 | No Comments »
Contrary to earlier findings, surgical breast biopsies may not be as overused as previously thought, according to a study in the February issue of the Journal of the American College of Radiology. Surgical breast biopsies are more invasive than needle biopsies, requiring an incision and the use of general anesthesia…
More: continued here
Filed under: Breast Cancer on February 3rd, 2012 | No Comments »